These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epigenetic biomarkers in prostate cancer: Current and future uses. Chiam K; Ricciardelli C; Bianco-Miotto T Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123 [TBL] [Abstract][Full Text] [Related]
3. [Men with breast cancer have increased risk of other cancers]. Lorphelin H; Mortemousque I; Marret H; Body G; Ouldamer L Presse Med; 2014 Apr; 43(4 Pt 1):e33-8. PubMed ID: 24612706 [TBL] [Abstract][Full Text] [Related]
4. [Molecular pathology of multifocal prostate cancer and its clinical application]. Cheng L; Teng XD; Zhou J Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):436-9. PubMed ID: 22088367 [No Abstract] [Full Text] [Related]
5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787 [TBL] [Abstract][Full Text] [Related]
6. [The Campaign Program for Prostate Integrated Research]. Cussenot O Bull Cancer; 2010 Dec; 97(12):1497-8. PubMed ID: 21284142 [No Abstract] [Full Text] [Related]
7. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. Dobosy JR; Roberts JL; Fu VX; Jarrard DF J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351 [TBL] [Abstract][Full Text] [Related]